ALBERTO VENTOSO CASTIÑEIRA-rekin lankidetzan egindako argitalpenak (10)
2021
-
Early tacrolimus exposure does not impact long-term outcomes after liver transplantation
World Journal of Hepatology, Vol. 13, Núm. 3, pp. 362-374
2020
-
Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus
Transplantation Proceedings, Vol. 52, Núm. 5, pp. 1489-1492
2018
-
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522
2016
-
Favorable longterm outcomes of liver transplant recipients treated de novo with once-daily tacrolimus: Results of a single-center cohort
Liver Transplantation, Vol. 22, Núm. 10, pp. 1391-1400
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
-
Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study
American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687
2012
-
Does the transjugular intrahepatic portosystemic influence the outcome of liver transplantation?
Transplantation Proceedings
2011
-
Advagraf de novo in liver transplantation: A single-center experience
Transplantation Proceedings
2010
-
Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
Transplantation Proceedings, Vol. 42, Núm. 2, pp. 660-662
2009
-
Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R-) Liver Transplant Recipients: A Single-Center Experience
Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2189-2191